Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-01-31 12:11 pm Purchase | 2024-01-22 | 13D | Dianthus Therapeutics, Inc. DNTH | Avidity Partners Management LP | 2,922,823 9.900% | 2,922,823![]() (New Position) | Filing History |
2024-01-24 5:26 pm Purchase | 2024-01-22 | 13D | Dianthus Therapeutics, Inc. DNTH | Fairmount Funds Management LLC | 2,960,747 9.900% | 1,086,914![]() (+58.00%) | Filing History |
2023-11-13 09:02 am Purchase | 2023-11-10 | 13G | Dianthus Therapeutics, Inc. DNTH | FMR LLC | 2,218,212 14.970% | 2,218,212![]() (New Position) | Filing History |
2023-09-21 4:34 pm Purchase | 2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH | Viridian LLC | 1,090,283 7.400% | 1,090,283![]() (New Position) | Filing History |
2023-09-21 4:32 pm Purchase | 2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH | Fairmount Funds Management LLC | 1,873,833 12.700% | 1,873,833![]() (New Position) | Filing History |
2023-09-21 4:15 pm Purchase | 2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH | 5AM Partners VII, LLC | 1,482,320 10.000% | 1,482,320![]() (New Position) | Filing History |
2023-09-21 4:15 pm Purchase | 2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III, L.P. | 927,706 6.300% | 927,706![]() (New Position) | Filing History |
2023-09-15 4:56 pm Purchase | 2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH | Atlas Venture Fund X L.P. | 186,089 1.300% | 186,089![]() (New Position) | Filing History |
2023-05-15 4:47 pm Purchase | 2023-05-03 | 13G | Magenta Therapeutics, Inc. MGTA | Citadel Advisors LLC | 4,087,110 6.700% | 4,087,110![]() (New Position) | Filing History |
2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | RA Capital Management, L.P. | 0 0.000% | -3,588,081![]() (Position Closed) | Filing History |
2023-02-14 11:12 am Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Aquilo Capital Management LLC | 0 0.000% | -3,155,082![]() (Position Closed) | Filing History |
2023-02-14 08:47 am Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Deep Track Capital, LP | 3,000,000 4.950% | -1,870,000![]() (-38.40%) | Filing History |
2023-02-14 06:09 am Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | GILDER GAGNON HOWE & CO LLC | 425,858 0.700% | -3,249,750![]() (-88.41%) | Filing History |
2023-02-13 9:31 pm Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Casdin Capital, LLC | 0 0.000% | -3,901,589![]() (Position Closed) | Filing History |
2023-02-13 4:00 pm Purchase | 2023-02-03 | 13G | Magenta Therapeutics, Inc. MGTA | TANG CAPITAL PARTNERS LP | 5,880,933 9.700% | 5,880,933![]() (New Position) | Filing History |
2022-09-27 10:40 am Unchanged | 2022-09-15 | 13G | Magenta Therapeutics, Inc. MGTA | RA Capital Management, L.P. | 3,588,081 6.090% | 0 (Unchanged) | Filing History |
2022-09-26 4:37 pm Purchase | 2022-09-15 | 13G | Magenta Therapeutics, Inc. MGTA | RA Capital Management, L.P. | 3,588,081 6.090% | 3,588,081![]() (New Position) | Filing History |
2022-05-05 4:01 pm Sale | 2021-04-13 | 13D | Magenta Therapeutics, Inc. MGTA | Atlas Venture Fund X L.P. | 2,977,448 5.100% | -379,892![]() (-11.32%) | Filing History |
2022-02-14 4:53 pm Purchase | 2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Third Rock Ventures IV L.P. | 6,758,204 11.500% | 6,758,204![]() (New Position) | Filing History |
2022-02-14 3:09 pm Purchase | 2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Aquilo Capital Management LLC | 3,155,082 5.400% | 3,155,082![]() (New Position) | Filing History |